Gloomy forecast for Swiss healthcare system:
This article was originally published in Clinica
Executive Summary
Healthcare costs in Switzerland increased from SwFr 12,400 million in 1980 to SwFr 24,500 million in 1990 and are expected to rise 5.9% per annum by the year 2005, according to a study entitled The Swiss Healthcare System in the Year 2005. The report recommends cutting costs through: a reduction in hospital beds; a shift from inpatient to outpatient treatment; a limit on the number of doctors permitted to practise; the development of new types of health insurance; and a higher level of direct patient contributions. Many medical procedures may only be available through supplementary insurance by the year 2005 and only 60% of the population is likely to be comprehensively insured.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.